Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-03-11
Target enrollment:
Participant gender:
Summary
The study has been designed as a 48-week, double-blind, randomized, controlled study
comparing the use of leflunomide alone to combinations of leflunomide-sulfasalazine-HCQ, and
methotrexate-sulfasalazine-HCQ.